Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07KUN
|
||||
Former ID |
DIB015580
|
||||
Drug Name |
RAD-1901
|
||||
Synonyms |
ER-306323; ER-308698; SERMs, Eisai/Radius; Selective estrogen receptor modulators, Eisai/Radius
|
||||
Indication | Breast cancer [ICD9: 174, 175; ICD10:C50] | Phase 2 | [522627] | ||
Company |
Eisai Co Ltd
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1(ccc(cc1)CN(c1c(ccc(c1)OC)[C@H]1Cc2c(CC1)cc(cc2)O)CC)<br />CCNCC
|
||||
Target and Pathway | |||||
Target(s) | Estrogen receptor | Target Info | Modulator | [533286] | |
Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
Signaling events mediated by HDAC Class II | |||||
Plasma membrane estrogen receptor signaling | |||||
LKB1 signaling events | |||||
Regulation of Telomerase | |||||
ATF-2 transcription factor network | |||||
AP-1 transcription factor network | |||||
FOXM1 transcription factor network | |||||
Validated nuclear estrogen receptor alpha network | |||||
Signaling mediated by p38-alpha and p38-beta | |||||
FOXA1 transcription factor network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.